Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
Dr Nazik Hammad speaks to ecancer on the gaps in the workforce delivering cancer care.
She outlines the quality problems by underusing and overusing supportive measures as well as the misuse of cancer care. She also addresses the role of the workforce in implementing Choosing Wisely in cancer care.
To see Dr Hammad’s full presentation click here.
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care
NSIA and BVGH aim to improve patient outcomes and access to quality cancer care
Management of prostate cancer in Africa: Looking to the future
The current status of multiple myeloma diagnosis and treatment
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital